<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02344459</url>
  </required_header>
  <id_info>
    <org_study_id>36685-D</org_study_id>
    <nct_id>NCT02344459</nct_id>
  </id_info>
  <brief_title>Comparing 30mL Single Versus 80mL Double Balloon Catheters for Pre-induction Cervical Ripening</brief_title>
  <official_title>Randomized Controlled Trial: Comparing 30mL Single Versus 80mL Double Balloon Catheters for Pre-induction Cervical Ripening</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Washington</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Washington</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to perform a randomized controlled trial to compare the efficacy
      of 80mL double balloon catheter versus a 30mL single catheter balloon for pre-induction
      cervical ripening by evaluating the change in Bishop score.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bishop score greater than or equal to 6 at time of balloon catheter removal</measure>
    <time_frame>until catheter removal (12 hours maximum)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>induction to delivery time</measure>
    <time_frame>The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>vaginal delivery time less than 24 hours from initiation of induction</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mode of delivery</measure>
    <time_frame>The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to catheter expulsion</measure>
    <time_frame>Up to 12 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Type of catheter expulsion</measure>
    <time_frame>The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)</time_frame>
    <description>spontaneous vs. provider</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Epidural utilization</measure>
    <time_frame>The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Meconium stained amniotic fluid</measure>
    <time_frame>The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>5 minute Apgar score</measure>
    <time_frame>The participants infant will be monitored from immediately to 5 minutes after birth</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medication required to augment labor</measure>
    <time_frame>The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)</time_frame>
    <description>prostaglandins, oxytocin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Artificial rupture of membranes required to augment labor</measure>
    <time_frame>The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cesarean section indications</measure>
    <time_frame>The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal intensive care unit admissions</measure>
    <time_frame>The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chorioamnionitis</measure>
    <time_frame>The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>birthweight</measure>
    <time_frame>The participant will be monitored from time of admission until delivery, an expected average of 24-48 hours of the infant (on average 24-48 hours)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">105</enrollment>
  <condition>Pre-induction Cervical Ripening</condition>
  <arm_group>
    <arm_group_label>80mL double balloon catheter (Cook catheter®)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>30mL single Foley balloon catheter</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>mechanical pre-induction cervical ripening</intervention_name>
    <description>The balloon catheters have been used to provide mechanical dilation to the cervix as a method of pre-induction cervical ripening.</description>
    <arm_group_label>80mL double balloon catheter (Cook catheter®)</arm_group_label>
    <arm_group_label>30mL single Foley balloon catheter</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Bishop score of 5 or less

          -  Singleton

          -  Cephalic presentation

          -  Fewer than 4 contractions in 10 minutes

          -  Reactive fetal monitoring

        Exclusion Criteria:

          -  Non-vertex presentation

          -  Placenta previa

          -  Vasa previa

          -  Unexplained vaginal bleeding

          -  Active herpes simplex virus infection

          -  Non-English speaking

          -  Previous attempt at an induction of labor in the current pregnancy

          -  Prolapsed umbilical cord

          -  More than one prior cesarean delivery or history of classical cesarean delivery

          -  Patients receiving or planning to undergo exogenous prostaglandin administration as
             the primary induction agent
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kara K Hoppe, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Washington</affiliation>
  </overall_official>
  <verification_date>January 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 1, 2014</study_first_submitted>
  <study_first_submitted_qc>January 16, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 26, 2015</study_first_posted>
  <last_update_submitted>January 16, 2015</last_update_submitted>
  <last_update_submitted_qc>January 16, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 26, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Washington</investigator_affiliation>
    <investigator_full_name>Kara Hoppe</investigator_full_name>
    <investigator_title>Maternal Fetal Medicine Fellow</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

